Arrowstreet Capital
FURX

Arrowstreet Capital’s FURIEX PHARMACEUTICALS INC COM STK (DE) FURX Stock Holding History

Arrowstreet Capital’s Portfolio FURX Stock Details FURX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-24,302
Closed -$1.02M – 1521
2013
Q4 		$1.02M Buy
24,302
+4,440
+22% +$183K 0.01% 822
2013
Q3 		$874K Buy
19,862
+959
+5% +$39.7K 0.01% 700
2013
Q2 		$644K Buy
+18,903
New +$664K ﹤0.01% 602

Other funds holding FURX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Arrowstreet Capital's FURX Position: Q1 2014 in Review

Arrowstreet Capital sold out of FURIEX PHARMACEUTICALS INC COM STK (DE) (FURX) in Q1 2014, closing a stake of 24,302 shares — an estimated $1.02M sold.

Arrowstreet Capital first reported a position in FURX in Q2 2013 and held it in 3 quarters. The position peaked at $1.02M in Q4 2013. 114 funds tracked by Wall St. Rank hold FURX as of Q1 2014.

  • Arrowstreet Capital reported no remaining FURIEX PHARMACEUTICALS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 24,302 FURIEX PHARMACEUTICALS INC COM STK (DE) shares in Q1 2014, an estimated $1.02M.
  • Arrowstreet Capital first reported a position in FURIEX PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • Arrowstreet Capital's FURIEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.02M in Q4 2013.
  • 114 funds tracked by Wall St. Rank held FURIEX PHARMACEUTICALS INC COM STK (DE) as of Q1 2014.

Based on Arrowstreet Capital's 13F filing for Q1 2014, filed 15 May 2014.